https://www.selleckchem.com/pr....oducts/Rapamycin.htm
system. This article is protected by copyright. All rights reserved. Aim of this study is to evaluate short term safety and efficacy of Impella in high risk percutaneous coronary intervention (HR-PCI) population. While several studies demonstrated the clinical significance of Impella in HR-PCI, few data exist about its impact on short term outcome. All studies reporting short term outcomes of PCI with any Impella device were included. The primary endpoint was either in-hospital or 30-day mortality, while vascular complications, post-p
Like
Comment
Share
